6 April 2026

Last updated: Sunday 5 April 2026

Research Directory

The steps ahead for Britain and the unitary patent

JP Morgan forum ends on a positive note

Biotechs post higher values in 2016 fourth quarter

Market Commentary: How risky are European biotechs?

The stately progress of antibiotics

Global oncology has many first-in-class compounds

Cheap capital gives rise to integrated pharma R&D

Commentary: Thought disruption in R&D discovery

Market Analysis: The outlook for European pharma

New risk capital for European companies